arrow
M

Marco Massari

n italian national institute of health
H指数:36
被引数:7,161

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ten-year trend of rituximab use for hematological malignancies: a multiregional real-world study using the Italian VALORE distributed database network

利妥昔单抗用于血液系统恶性肿瘤的十年趋势:一项基于意大利VALORE分布式数据库网络的跨区域真实世界研究

2025-11-050
PRE
Frequency of Biological Drug Use in Older Patients with Immune-Mediated Inflammatory Diseases: Results from the Large-Scale Italian VALORE Distributed Database Network

老年免疫介导性炎症疾病患者生物制剂使用频率:来自意大利VALORE分布式数据库网络的大规模研究结果

2025-04-030
OA
Trajectories of biologic drug use before, during and after pregnancy: an Italian cohort study from the VALORE project
2024-12-210
OA
Risk of breakthrough infection and hospitalisation after COVID-19 primary vaccination by HIV status in four Italian regions during 2021
2024-06-110
OAAI
Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER HCV)
2024-04-263
OAAI
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B

解除调节的细胞内途径为慢性乙型肝炎中的HBV特异性CD8 T细胞重建定义了新的分子靶标

2023-07-0110
PRE
Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort
2023-07-0111
OAAI
Modifications of Chest CT Body Composition Parameters at Three and Six Months after Severe COVID-19 Pneumonia: A Retrospective Cohort Study
2022-09-133
OAAI
Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trial
2022-03-3139
OAAI
Inflammatory burden and persistent CT lung abnormalities in COVID-19 patients
2022-03-116
OAAI
A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort

意大利PITER队列对HCV冷球蛋白血症血管炎的直接作用抗病毒有效性和复发风险的前瞻性研究

2022-01-1914
OAAI
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort
2021-12-013
OAAI
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (vol 18, 405, 2020)
2021-10-211
OAAI
Liver function following hepatitis C virus eradication by direct acting antivirals in patients with liver cirrhosis: data from the PITER cohort
2021-05-0418
OAAI